Compare TXRH & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TXRH | RGC |
|---|---|---|
| Founded | 1993 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Restaurants | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 11.5B |
| IPO Year | 2004 | 2020 |
| Metric | TXRH | RGC |
|---|---|---|
| Price | $192.34 | $6.65 |
| Analyst Decision | Buy | |
| Analyst Count | 18 | 0 |
| Target Price | ★ $193.78 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 376.5K |
| Earning Date | 05-07-2026 | 10-31-2025 |
| Dividend Yield | ★ 1.70% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.87 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.46 | N/A |
| Revenue Next Year | $9.28 | N/A |
| P/E Ratio | $103.77 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $153.83 | $5.80 |
| 52 Week High | $197.00 | $69.00 |
| Indicator | TXRH | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 68.35 | 22.33 |
| Support Level | $165.83 | N/A |
| Resistance Level | $197.00 | $25.78 |
| Average True Range (ATR) | 5.57 | 2.28 |
| MACD | 1.96 | -0.44 |
| Stochastic Oscillator | 91.86 | 4.28 |
Texas Roadhouse Inc is a restaurant company operating predominantly in the casual dining segment. The company manages its restaurant and franchising operations by concept and, as a result, has identified Texas Roadhouse, Bubba's 33, Jaggers, and retail initiatives as separate operating segments. In addition, it has identified Texas Roadhouse and Bubba's 33 as reportable segments. Maximum revenue for the company is generated from the Texas Roadhouse segment, which is a moderately priced, full-service, casual dining restaurant concept offering steaks, a selection of ribs, seafood, chicken, pork chops, pulled pork, vegetable plates, and an assortment of hamburgers, salads, and sandwiches. Geographically, the majority of the firm's restaurants are in the USA, with a few in foreign countries.
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.